Literature DB >> 30177359

Intramedullary Cortical Button Repair for Distal Biceps Tendon Rupture: A Single-Center Experience.

Sebastian Siebenlist1, Andreas Schmitt1, Andreas B Imhoff1, Andreas Lenich2, Gunther H Sandmann3, Karl F Braun4, Chlodwig Kirchhoff4, Peter Biberthaler4, Arne Buchholz5.   

Abstract

PURPOSE: The aim of this retrospective study was to evaluate the clinical outcome and complication rate of intramedullary cortical button repair for distal biceps tendon rupture (partial and complete tears).
METHODS: Between 2010 and 2014, a total of 28 patients with an acute distal biceps tendon rupture underwent intramedullary cortical button repair. Twenty-four patients (mean age, 49 years) with a mean follow-up of 28 months were included in the study. Twenty patients were examined clinically and by maximum isometric strength testing in flexion (at 90°) and supination of both arms. Twenty-four patients completed functional scores including the Mayo Elbow Performance Score (MEPS), the Andrews-Carson-Score (ACS) and the shortened Disabilities of the Arm, Shoulder, and Hand (QuickDASH) questionnaire. Furthermore, follow-up radiographs of 24 patients were analyzed.
RESULTS: Compared with the contralateral elbow, the active range of motion (ROM) was the same. The mean strength for flexion was 100.8% ± 14% and for supination 93.1% ± 22% compared with the uninjured side. The mean MEPS for all patients was 95.6 ± 8.2, the mean ACS 194.2 ± 9.4 and the QuickDASH 3.8 ± 7.6. Heterotopic ossification (HO) was seen on radiographs in 46% of patients, but was symptomatic in only 1 patient. One patient suffered a tendon rerupture, and 1 asymptomatic button migration was seen in the follow-up.
CONCLUSIONS: Intramedullary cortical button repair provides good results with respect to strength, ROM, and functional outcomes. Because the posterior cortex is not violated, the risk of iatrogenic posterior interosseous nerve injury is minimized. However, the patient should be warned of a high prevalence of postoperative HO. TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic IV.
Copyright © 2019 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Distal biceps tendon; heterotopic ossification; intramedullary cortical button; posterior interosseous nerve

Year:  2018        PMID: 30177359     DOI: 10.1016/j.jhsa.2018.07.005

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  6 in total

1.  Anatomical intramedullary distal biceps tendon fixation. Our first experience.

Authors:  Pieter Caekebeke; Laurens Van Melkebeke; Joris Duerinckx; Roger van Riet
Journal:  JSES Int       Date:  2022-02-14

2.  Successful Surgical Repair of Acute Quadriceps Tendon Rupture Utilizing Cortical Button Fixation: A Case Report.

Authors:  Andrew S Bae; Devin W Collins; Achraf H Jardaly; Patrick J Fernicola
Journal:  Am J Case Rep       Date:  2021-12-23

Review 3.  Operative Versus Nonoperative Management for Distal Biceps Brachii Tendon Lesions: A Systematic Review and Meta-analysis.

Authors:  Marco Cuzzolin; Davide Secco; Enrico Guerra; Sante Alessandro Altamura; Giuseppe Filardo; Christian Candrian
Journal:  Orthop J Sports Med       Date:  2021-10-29

4.  Subpectoral Biceps Tenodesis: All-Suture Anchor Onlay Technique.

Authors:  Lucca Lacheta; Andreas B Imhoff; Sebastian Siebenlist; Bastian Scheiderer
Journal:  Arthrosc Tech       Date:  2020-04-25

5.  Low mental health scores are associated with worse patient-reported outcomes and difficulty with return to work and sport after distal biceps repair.

Authors:  Thomas Yetter; Andrew G Patton; Ahmed Mansi; Nicholas Maassen; Jeremy S Somerson
Journal:  JSES Int       Date:  2021-03-02

Review 6.  [Acute rupture of the pectoralis major muscle at the musculotendinous junction : Case report of a rare injury and literature review].

Authors:  Maximilian Hinz; Benjamin D Kleim; Felix Mayr; Andreas B Imhoff; Sebastian Siebenlist
Journal:  Unfallchirurg       Date:  2021-04-19       Impact factor: 1.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.